Tylosin 10 gm/100 ml Injection

Tylosin 10 gm/100 ml injection by Jams Pharmaceuticals Ltd. contains Tylosin, a macrolide antibiotic mainly used in Bangladesh for veterinary treatment of susceptible bacterial and Mycoplasma infections in poultry, livestock, and other animals as directed by a veterinarian.

Tylosin works by inhibiting bacterial protein synthesis, which slows or stops the growth of susceptible organisms. A key caution is that it is not a routine human medicine and should not be used in people or animals without professional guidance.

• Veterinary treatment or control of infections caused by tylosin-susceptible organisms, including certain Mycoplasma and Gram-positive bacterial infections.
• May be used in poultry, swine, cattle, or other approved animal species for respiratory, enteric, or other infections where local product approval and veterinary diagnosis support its use.
• Uses vary by country, species, formulation, and product label; follow the registered veterinary indication and withdrawal-period instructions.

There is no established standard adult human dose for Tylosin because tylosin is primarily a veterinary antibiotic and is not intended for routine human use. Dose, route, duration, and withdrawal period depend on the animal species, body weight, infection, formulation, and local product label. Use only the dose prescribed by a registered veterinarian or other appropriately qualified professional.

• Gastrointestinal upset in animals, such as reduced appetite, vomiting, diarrhea, or loose stools.
• Pain, swelling, or irritation at the injection site.
• Allergic reactions such as rash, swelling, breathing difficulty, or collapse; seek urgent help if these occur.
• Severe or persistent diarrhea may indicate serious intestinal disturbance and needs veterinary attention.
• In horses and some small herbivores, macrolide antibiotics can cause severe, sometimes fatal, colitis.

Use caution in animals with a history of allergy to macrolide antibiotics, significant liver disease, severe gastrointestinal disease, or in species known to be sensitive to gut-flora disruption. Do not use in food-producing animals unless the correct meat, milk, or egg withdrawal period can be followed. Use Tylosin only under a registered doctor's, pharmacist's, or veterinarian's guidance, as appropriate.

• Other antibiotics that act on the bacterial ribosome, such as lincosamides or chloramphenicol, may interfere with macrolide activity; combine only if prescribed.
• Concurrent use with other potentially liver-affecting medicines should be assessed by a professional.
• Antibiotics may reduce the effectiveness of live bacterial vaccines or probiotic preparations if given at the same time.
• For food-producing animals, observe label restrictions and withdrawal periods for meat, milk, and eggs.

• Known hypersensitivity to tylosin, other macrolide antibiotics, or any formulation ingredient.
• Use in horses or equines unless specifically directed by a veterinarian, due to risk of severe or fatal colitis.
• Use in rabbits, guinea pigs, hamsters, and similar small herbivores unless a veterinarian determines it is appropriate.
• Human self-medication with tylosin is contraindicated because it is not a standard human antibiotic.

For pregnant, breeding, or lactating animals, Tylosin should be used only when a veterinarian judges that the expected benefit outweighs the risk. In food-producing animals, strictly follow milk, egg, and meat withdrawal instructions. It should not be used by pregnant or breastfeeding people for self-treatment.

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep the container tightly closed and out of reach of children and animals. Reconstituted or mixed preparations should be used within the time stated on the product label and any unused portion discarded safely.